Medicine details

Treatment of children with: growth failure due to growth hormone deficiency; growth failure in girls due to gonadal dysgenesis (Turner syndrome); growth retardation in prepubertal children due to chronic renal disease; growth disturbance (current height SDS < -2.5 and parental adjusted height SDS < -1) in short children born small for gestational age (SGA), with a birth weight and/or length below -2 SD, who failed to show catch-up growth (HV SDS < 0 during the last year) by 4 years of age or later Treatment of adult patients with: pronounced growth hormone deficiency in known hypothalamic-pituitary disease (one other deficient axis, other than prolactin), demonstrated by one provocative test after institution of adequate replacement therapy for any other deficient axis; childhood onset growth hormone insufficiency, reconfirmed by two provocative tests

TA188: Human growth hormone (somatropin) for the treatment of growth failure in children (replaced TA42)